Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

Market Cap	45.05B
Revenue (ttm)	79.90B
Net Income (ttm)	2.89B
Shares Out	1.63B
EPS (ttm)	1.78
PE Ratio	10.11
Forward PE	8.78
Dividend	0.88 (4.89%)
Ex-Dividend Date	Jun 16, 2025

Volume	614,000
Average Volume	1,071,796
Open	17.98
Previous Close	18.00
Day's Range	17.86 - 18.06
52-Week Range	15.76 - 24.00
Beta	0.54
RSI	59.56
Earnings Date	Aug 16, 2025

About HKG:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical ins...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1997
• Employees: 28,048
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0874

Financial Performance

In 2024, HKG:0874's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.

Financial numbers in CNY